These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
HIV Capsid Inhibitor Capacity of Different Isomers of Di-Pyridine Benzene and Its Alkyl and Halide Derivatives
preprintsubmitted on 16.10.2019, 19:06 and posted on 21.10.2019, 20:54 by Nilanjana Biswas, Sangita Ghosh, Arijit Bag
HIV-1 Capsid-A inhibitor capacity of different isomers of di-pyridine benzene and its alkyl and halide derivatives are studied systematically. It is found that p-di-pyridine o-ethyl benzene has very good inhibition constant. It is a small, cost effective organic compound and very promising as a HIV drug. It is a molecular docking based study.